Loading...

Megan E Daly

TitleASSOC PROF OF CLIN-HCOMP
InstitutionUniversity of California Davis
DepartmentRadiation Oncology
Address4501 X Street Suite G140
CA 95817
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Nguyen KB, Hause D, Novak J, Monjazeb AM, Daly ME. Tumor Control and Toxicity Following SBRT for Ultracentral, Central and Paramediastinal Lung Tumors. Pract Radiat Oncol. 2018 Nov 26. PMID: 30496842.
      View in: PubMed
    2. Rash D, Daly ME, Durbin-Johnson B, Vaughan AT, Chen AM. Treatment outcomes in HPV-negative oropharyngeal cancer: Surgery plus radiotherapy vs. definitive chemoradiotherapy. Ear Nose Throat J. 2018 Aug; 97(8):E1-E7. PMID: 30138518.
      View in: PubMed
    3. Yamamoto T, Kabus S, Bal M, Bzdusek K, Keall PJ, Wright C, Benedict SH, Daly ME. Changes in Regional Ventilation During Treatment and Dosimetric Advantages of CT Ventilation Image Guided Radiation Therapy for Locally Advanced Lung Cancer. Int J Radiat Oncol Biol Phys. 2018 May 04. PMID: 29891207.
      View in: PubMed
    4. Daly ME. Consolidative Thoracic Radiation and Serial Central Nervous System Imaging. Int J Radiat Oncol Biol Phys. 2018 May 01; 101(1):6. PMID: 29619977.
      View in: PubMed
    5. McGee HM, Daly ME, Azghadi S, Stewart SL, Oesterich L, Schlom J, Donahue R, Schoenfeld JD, Chen Q, Rao S, Fragoso RC, Valicenti RK, Canter RJ, Maverakis EM, Murphy WJ, Kelly K, Monjazeb AM. Stereotactic Ablative Radiation Therapy Induces Systemic Differences in Peripheral Blood Immunophenotype Dependent on Irradiated Site. Int J Radiat Oncol Biol Phys. 2018 Apr 22. PMID: 29891204.
      View in: PubMed
    6. Dyer BA, Daly ME. Surveillance imaging following definitive radiotherapy for non-small cell lung cancer: What is the clinical impact? Semin Oncol. 2017 Oct; 44(5):303-309. PMID: 29580432.
      View in: PubMed
    7. Moghanaki D, Simone CB, Rimner A, Karas TZ, Donington J, Shirvani SM, Daly M, Videtic GM, Movsas B. The value of collaboration between thoracic surgeons and radiation oncologists while awaiting evidence in operable stage i non-small cell lung cancer. J Thorac Cardiovasc Surg. 2018 Jan; 155(1):429-431. PMID: 29245205.
      View in: PubMed
    8. Schneider BJ, Daly ME, Kennedy EB, Stiles BM. Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline Summary. J Oncol Pract. 2018 Mar; 14(3):180-186. PMID: 29257717.
      View in: PubMed
    9. Hegde JV, Shaverdian N, Felix C, Wang PC, Veruttipong D, Hsu S, Riess JW, Rao SD, Daly ME, Chen AM. Functional Outcomes After De-escalated Chemoradiation Therapy for Human Papillomavirus-Positive Oropharyngeal Cancer: Secondary Analysis of a Phase 2 Trial. Int J Radiat Oncol Biol Phys. 2018 Mar 01; 100(3):647-651. PMID: 29246721.
      View in: PubMed
    10. Schneider BJ, Daly ME, Kennedy EB, Antonoff MB, Broderick S, Feldman J, Jolly S, Meyers B, Rocco G, Rusthoven C, Slotman BJ, Sterman DH, Stiles BM. Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline. J Clin Oncol. 2018 Mar 01; 36(7):710-719. PMID: 29106810.
      View in: PubMed
    11. Hegde JV, Shaverdian N, Daly ME, Felix C, Wong DL, Rosove MH, Garst JH, Wang PC, Veruttipong D, Rao S, Fragoso RC, Riess JW, Steinberg ML, Chen AM. Patient-reported quality-of-life outcomes after de-escalated chemoradiation for human papillomavirus-positive oropharyngeal carcinoma: Findings from a phase 2 trial. Cancer. 2018 Feb 01; 124(3):521-529. PMID: 29044458.
      View in: PubMed
    12. Daly ME, Palma DA. Prophylactic Cranial Irradiation for Small Cell Lung Cancer: New Insights. Int J Radiat Oncol Biol Phys. 2017 09 01; 99(1):3-5. PMID: 28816157.
      View in: PubMed
    13. Dyer BA, Nguyen KNB, Shukla RP, Li T, Daly ME. Durable Local Control Following Concurrent Hypofractionated Chemoradiation for a Massive Inflammatory Breast Cancer Chest Wall Recurrence. Cureus. 2017 Jun 21; 9(6):e1379. PMID: 28775919.
      View in: PubMed
    14. Videtic GMM, Donington J, Giuliani M, Heinzerling J, Karas TZ, Kelsey CR, Lally BE, Latzka K, Lo SS, Moghanaki D, Movsas B, Rimner A, Roach M, Rodrigues G, Shirvani SM, Simone CB, Timmerman R, Daly ME. Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline. Pract Radiat Oncol. 2017 Sep - Oct; 7(5):295-301. PMID: 28596092.
      View in: PubMed
    15. Moran A, Daly ME, Yip SSF, Yamamoto T. Radiomics-based Assessment of Radiation-induced Lung Injury After Stereotactic Body Radiotherapy. Clin Lung Cancer. 2017 Nov; 18(6):e425-e431. PMID: 28623121.
      View in: PubMed
    16. Chen AM, Felix C, Wang PC, Hsu S, Basehart V, Garst J, Beron P, Wong D, Rosove MH, Rao S, Melanson H, Kim E, Palmer D, Qi L, Kelly K, Steinberg ML, Kupelian PA, Daly ME. Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study. Lancet Oncol. 2017 Jun; 18(6):803-811. PMID: 28434660.
      View in: PubMed
    17. Tam K, Daly M, Kelly K. Treatment of Locally Advanced Non-Small Cell Lung Cancer. Hematol Oncol Clin North Am. 2017 02; 31(1):45-57. PMID: 27912833.
      View in: PubMed
    18. David EA, Daly ME, Li CS, Chiu CL, Cooke DT, Brown LM, Melnikow J, Kelly K, Canter RJ. Increasing Rates of No Treatment in Advanced-Stage Non-Small Cell Lung Cancer Patients: A Propensity-Matched Analysis. J Thorac Oncol. 2017 03; 12(3):437-445. PMID: 28109804.
      View in: PubMed
    19. Tembhekar AR, Wright CL, Daly ME. Cardiac Dose and Survival After Stereotactic Body Radiotherapy for Early-stage Non-Small-cell Lung Cancer. Clin Lung Cancer. 2017 05; 18(3):293-298. PMID: 28089158.
      View in: PubMed
    20. Ho QA, Harandi NK, Daly ME. Clinical Impact of Frequent Surveillance Imaging in the First Year Following Chemoradiation for Locally Advanced Non-small-cell Lung Cancer. Clin Lung Cancer. 2017 07; 18(4):410-414. PMID: 28007410.
      View in: PubMed
    21. Verma V, Simone CB, Allen PK, Gajjar SR, Shah C, Zhen W, Harkenrider MM, Hallemeier CL, Jabbour SK, Matthiesen CL, Braunstein SE, Lee P, Dilling TJ, Allen BG, Nichols EM, Attia A, Zeng J, Biswas T, Paximadis P, Wang F, Walker JM, Stahl JM, Daly ME, Decker RH, Hales RK, Willers H, Videtic GM, Mehta MP, Lin SH. Multi-Institutional Experience of Stereotactic Ablative Radiation Therapy for Stage I Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2017 02 01; 97(2):362-371. PMID: 28011047.
      View in: PubMed
    22. Daly ME, Lara PN. Local Radiation for Extensive Stage Small Cell Lung Cancer: A Step Forward or Running in Place? Clin Lung Cancer. 2016 07; 17(4):237-8. PMID: 27346548.
      View in: PubMed
    23. Azghadi S, Daly M, Mayadev J. Practice Patterns of Radiation Field Design for Sentinel Lymph Node-Positive Early-Stage Breast Cancer. Clin Breast Cancer. 2016 Oct; 16(5):410-417.e3. PMID: 27266803.
      View in: PubMed
    24. Daly ME, Riess JW. Multidisciplinary Care. Cancer Treat Res. 2016; 170:285-300. PMID: 27535399.
      View in: PubMed
    25. Yamamoto T, Kabus S, Bal M, Keall P, Benedict S, Daly M. The first patient treatment of computed tomography ventilation functional image-guided radiotherapy for lung cancer. Radiother Oncol. 2016 Feb; 118(2):227-31. PMID: 26687903.
      View in: PubMed
    26. Daly ME, Monjazeb AM, Kelly K. Clinical Trials Integrating Immunotherapy and Radiation for Non-Small-Cell Lung Cancer. J Thorac Oncol. 2015 Dec; 10(12):1685-93. PMID: 26484629.
      View in: PubMed
    27. Ling DC, Hess CB, Chen AM, Daly ME. Comparison of Toxicity Between Intensity-Modulated Radiotherapy and 3-Dimensional Conformal Radiotherapy for Locally Advanced Non-small-cell Lung Cancer. Clin Lung Cancer. 2016 Jan; 17(1):18-23. PMID: 26303127; PMCID: PMC4707098 [Available on 01/01/17].
    28. Harris BN, Biron VL, Donald P, Farwell DG, Luu QC, Bewley AF, Chen AM, Daly ME. Primary Surgery vs Chemoradiation Treatment of Advanced-Stage Hypopharyngeal Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg. 2015 Jul; 141(7):636-40. PMID: 25973578.
      View in: PubMed
    29. Hayes JT, David EA, Qi L, Chen AM, Daly ME. Risk of Pneumonitis After Stereotactic Body Radiation Therapy in Patients With Previous Anatomic Lung Resection. Clin Lung Cancer. 2015 Sep; 16(5):379-84. PMID: 25737143; PMCID: PMC4521988.
    30. Hess C, Lee A, Fish K, Daly M, Cress RD, Mayadev J. Socioeconomic and racial disparities in the selection of chest wall boost radiation therapy in californian women after mastectomy. Clin Breast Cancer. 2015 Jun; 15(3):212-8. PMID: 25499694; PMCID: PMC4484791.
    31. Yu Y, Daly ME, Farwell DG, Luu Q, Gandour-Edwards R, Donald PJ, Chen AM. Level IB nodal involvement in oropharyngeal carcinoma: implications for submandibular gland-sparing intensity-modulated radiotherapy. Laryngoscope. 2015 Mar; 125(3):608-14. PMID: 25215891.
      View in: PubMed
    32. Daly ME, Chen AM, Mayadev JS, Stern RL. Enhanced surface dose via fine brass mesh for a complex skin cancer of the head and neck: report of a technique. Pract Radiat Oncol. 2015 Jan-Feb; 5(1):16-20. PMID: 25413387.
      View in: PubMed
    33. Chen AM, Daly ME, Luu Q, Donald PJ, Farwell DG. Comparison of functional outcomes and quality of life between transoral surgery and definitive chemoradiotherapy for oropharyngeal cancer. Head Neck. 2015 Mar; 37(3):381-5. PMID: 24431059.
      View in: PubMed
    34. Hess CB, Rash DL, Daly ME, Farwell DG, Bishop J, Vaughan AT, Wilson MD, Chen AM. Competing causes of death and medical comorbidities among patients with human papillomavirus-positive vs human papillomavirus-negative oropharyngeal carcinoma and impact on adherence to radiotherapy. JAMA Otolaryngol Head Neck Surg. 2014 Apr; 140(4):312-6. PMID: 24526276; PMCID: PMC4397215.
    35. Chen AM, Yu Y, Daly ME, Farwell DG, Benedict SH, Purdy JA. Long-term experience with reduced planning target volume margins and intensity-modulated radiotherapy with daily image-guidance for head and neck cancer. Head Neck. 2014 Dec; 36(12):1766-72. PMID: 24174221.
      View in: PubMed
    36. Chen AM, Daly ME, Farwell DG, Vazquez E, Courquin J, Lau DH, Purdy JA. Quality of life among long-term survivors of head and neck cancer treated by intensity-modulated radiotherapy. JAMA Otolaryngol Head Neck Surg. 2014 Feb; 140(2):129-33. PMID: 24337483.
      View in: PubMed
    37. Chen AM, Daly ME, Cui J, Mathai M, Benedict S, Purdy JA. Clinical outcomes among patients with head and neck cancer treated by intensity-modulated radiotherapy with and without adaptive replanning. Head Neck. 2014 Nov; 36(11):1541-6. PMID: 23996502.
      View in: PubMed
    38. Khodayari B, Daly ME, Bobinski M, Farwell DG, Shelton DK, Chen AM. Observation versus neck dissection for positron-emission tomography-negative lymphadenopathy after chemoradiotherapy. Laryngoscope. 2014 Apr; 124(4):902-6. PMID: 24115118.
      View in: PubMed
    39. Daly ME, Beckett LA, Chen AM. Does early posttreatment surveillance imaging affect subsequent management following stereotactic body radiation therapy for early-stage non-small cell lung cancer? Pract Radiat Oncol. 2014 Jul-Aug; 4(4):240-6. PMID: 25012832; PMCID: PMC4586160.
    40. Chen AM, Daly ME, Vazquez E, Courquin J, Luu Q, Donald PJ, Farwell DG. Depression among long-term survivors of head and neck cancer treated with radiation therapy. JAMA Otolaryngol Head Neck Surg. 2013 Sep; 139(9):885-9. PMID: 23949013.
      View in: PubMed
    41. Daly ME, Lau DH, Farwell DG, Luu Q, Donald PJ, Chen AM. Feasibility and toxicity of concurrent chemoradiation for elderly patients with head and neck cancer. Am J Otolaryngol. 2013 Nov-Dec; 34(6):631-5. PMID: 23954137.
      View in: PubMed
    42. Daly ME, Perks JR, Chen AM. Patterns-of-care for thoracic stereotactic body radiotherapy among practicing radiation oncologists in the United States. J Thorac Oncol. 2013 Feb; 8(2):202-7. PMID: 23222368.
      View in: PubMed
    43. Chen AM, Zahra T, Daly ME, Farwell DG, Luu Q, Gandour-Edwards R, Vaughan AT. Definitive radiation therapy without chemotherapy for human papillomavirus-positive head and neck cancer. Head Neck. 2013 Nov; 35(11):1652-6. PMID: 23335285; PMCID: PMC4757483.
    44. Hou WH, Daly ME, Lee NY, Farwell DG, Luu Q, Chen AM. Racial disparities in the use of voice preservation therapy for locally advanced laryngeal cancer. Arch Otolaryngol Head Neck Surg. 2012 Jul; 138(7):644-9. PMID: 22801888.
      View in: PubMed
    45. Daly ME, Kapp DS, Maxim PG, Welton ML, Tran PT, Koong AC, Chang DT. Orthovoltage intraoperative radiotherapy for locally advanced and recurrent colorectal cancer. Dis Colon Rectum. 2012 Jun; 55(6):695-702. PMID: 22595850.
      View in: PubMed
    46. Wiegner EA, Daly ME, Murphy JD, Abelson J, Chapman CH, Chung M, Yu Y, Colevas AD, Kaplan MJ, Fischbein N, Le QT, Chang DT. Intensity-modulated radiotherapy for tumors of the nasal cavity and paranasal sinuses: clinical outcomes and patterns of failure. Int J Radiat Oncol Biol Phys. 2012 May 01; 83(1):243-51. PMID: 22019239.
      View in: PubMed
    47. Daly ME, Choi CY, Gibbs IC, Adler JR, Chang SD, Lieberson RE, Soltys SG. Tolerance of the spinal cord to stereotactic radiosurgery: insights from hemangioblastomas. Int J Radiat Oncol Biol Phys. 2011 May 01; 80(1):213-20. PMID: 21481724.
      View in: PubMed
    48. Daly ME, Luxton G, Choi CY, Gibbs IC, Chang SD, Adler JR, Soltys SG. Normal tissue complication probability estimation by the Lyman-Kutcher-Burman method does not accurately predict spinal cord tolerance to stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 2012 Apr 01; 82(5):2025-32. PMID: 21531516.
      View in: PubMed
    49. Daly ME, Le QT, Jain AK, Maxim PG, Hsu A, Loo BW, Kaplan MJ, Fischbein NJ, Colevas AD, Pinto H, Chang DT. Intensity-modulated radiotherapy for locally advanced cancers of the larynx and hypopharynx. Head Neck. 2011 Jan; 33(1):103-11. PMID: 20848427.
      View in: PubMed
    50. Daly ME, Le QT, Kozak MM, Maxim PG, Murphy JD, Hsu A, Loo BW, Kaplan MJ, Fischbein NJ, Chang DT. Intensity-modulated radiotherapy for oral cavity squamous cell carcinoma: patterns of failure and predictors of local control. Int J Radiat Oncol Biol Phys. 2011 Aug 01; 80(5):1412-22. PMID: 20675073.
      View in: PubMed
    51. Chen AM, Daly ME, El-Sayed I, Garcia J, Lee NY, Bucci MK, Kaplan MJ. Patterns of failure after combined-modality approaches incorporating radiotherapy for sinonasal undifferentiated carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 2008 Feb 01; 70(2):338-43. PMID: 18207030.
      View in: PubMed
    52. Chen AM, Daly ME, Bucci MK, Xia P, Akazawa C, Quivey JM, Weinberg V, Garcia J, Lee NY, Kaplan MJ, El-Sayed I, Eisele DW, Fu KK, Phillips TL. Carcinomas of the paranasal sinuses and nasal cavity treated with radiotherapy at a single institution over five decades: are we making improvement? Int J Radiat Oncol Biol Phys. 2007 Sep 01; 69(1):141-7. PMID: 17459609.
      View in: PubMed
    53. Daly ME, Lieskovsky Y, Pawlicki T, Yau J, Pinto H, Kaplan M, Fee WE, Koong A, Goffinet DR, Xing L, Le QT. Evaluation of patterns of failure and subjective salivary function in patients treated with intensity modulated radiotherapy for head and neck squamous cell carcinoma. Head Neck. 2007 Mar; 29(3):211-20. PMID: 17111429.
      View in: PubMed
    54. Daly ME, Chen AM, Bucci MK, El-Sayed I, Xia P, Kaplan MJ, Eisele DW. Intensity-modulated radiation therapy for malignancies of the nasal cavity and paranasal sinuses. Int J Radiat Oncol Biol Phys. 2007 Jan 01; 67(1):151-7. PMID: 17189068.
      View in: PubMed